The proposed study aims to evaluate the impact on intestinal and oral microbiota composition and the metabolic effects of the daily consumption of a wheat-based fermented beverage, developed under the collaborative WHEATBIOME project, over a 4-week intervention period in healthy adults.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Gut microbiota
Timeframe: At visit 1 (Baseline) and visit 2 (end of intervention - 4 weeks)
Oral microbiota
Timeframe: At visit 1 (Baseline) and visit 2 (end of intervention - 4 weeks)
Fasting blood glucose
Timeframe: At visit 1 (Baseline) and visit 2 (end of intervention - 4 weeks)
Insulin
Timeframe: At visit 1 (Baseline) and visit 2 (end of intervention - 4 weeks)
Total cholesterol
Timeframe: At visit 1 (Baseline) and visit 2 (end of intervention - 4 weeks)
LDL cholesterol
Timeframe: At visit 1 (Baseline) and visit 2 (end of intervention - 4 weeks)
Triacylglycerides
Timeframe: At visit 1 (Baseline) and visit 2 (end of intervention - 4 weeks)
Exhaled breath gas profile
Timeframe: At visit 1 (Baseline) and visit 2 (end of intervention - 4 weeks)